Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for Oroville Hospital located at 2767 Olive Hwy, Oroville, CA, 95966 & includes data from NPIs 1871606269, 1679581557
Dexur analyzed Q4 2018 (October to December 2018) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for Oroville Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Oct 2018 to Dec 2018) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 1,585 | 1,437 | ||||||||||
| Surgical | 207 | 190 | ||||||||||
| Non Surgical | 1,378 | 1,247 | ||||||||||
| General Medicine | 606 | 538 | ||||||||||
| Cardiovascular | 245 | 219 | ||||||||||
| Gastroenterology & Endocrinology | 168 | 161 | ||||||||||
| Orthopedics | 133 | 123 | ||||||||||
| Neurology | 114 | 108 | ||||||||||
| Urology | 107 | 100 | ||||||||||
| General Surgery | 73 | 61 | ||||||||||
| Pulmonology | 72 | 66 | ||||||||||
| Oncology & Hematology | 22 | 19 | ||||||||||
| Psychiatry & Mental Disorders | 15 | 14 | ||||||||||
| Obstetrics & Gynecology | 14 | 12 | ||||||||||
| Dermatology | 11 | 11 |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Oct 2018 to Dec 2018) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Poisoning And Toxic Effects Of Drugs | ||||||||||||
| DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Signs And Symptoms | ||||||||||||
| DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Peptic Ulcer | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Oct 2018 to Dec 2018) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chest Pain | ||||||||||||
| DRG 313: CHEST PAIN | ||||||||||||
| Hypertension | ||||||||||||
| DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Oct 2018 to Dec 2018) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Diabetes | ||||||||||||
| DRG 637: DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Oct 2018 to Dec 2018) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 480: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Medical Back Problems | ||||||||||||
| DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| Signs And Symptoms Of Musculoskeletal System And Connective Tissue | ||||||||||||
| DRG 556: SIGNS AND SYMPTOMS OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Oct 2018 to Dec 2018) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Seizures | ||||||||||||
| DRG 100: SEIZURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Disorders Of Nervous System | ||||||||||||
| DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Transient Ischemia | ||||||||||||
| DRG 069: TRANSIENT ISCHEMIA | ||||||||||||
| Cranial And Peripheral Nerve Disorders | ||||||||||||
| DRG 074: CRANIAL AND PERIPHERAL NERVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Oct 2018 to Dec 2018) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Male Pelvic Procedures | ||||||||||||
| DRG 707: MAJOR MALE PELVIC PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Oct 2018 to Dec 2018) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 854: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | California Total Hospitalizations (Oct 2018 to Dec 2018) | California Total Hospitalizations After Exclusion | California Total Users | California SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| Respiratory Infections And Inflammations |